Education
About Us
Working with TipRanks
Follow Us
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 18.68B | ¥ 17.03B | ¥ 15.27B | ¥ 10.29B | ¥ 5.61B |
| Gross Profit | ¥ 7.65B | ¥ 6.83B | ¥ 6.72B | ¥ 4.83B | ¥ 2.53B |
| Operating Income | ¥ 4.97B | ¥ 4.45B | ¥ 4.34B | ¥ 3.19B | ¥ 1.50B |
| EBITDA | ¥ 6.43B | ¥ 5.50B | ¥ 6.22B | ¥ 4.51B | ¥ 2.31B |
| Net Income | ¥ 3.36B | ¥ 3.40B | ¥ 4.42B | ¥ 3.39B | ¥ 1.69B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 10.71B | ¥ 11.24B | ¥ 8.71B | ¥ 11.13B | ¥ 8.48B |
| Total Assets | ¥ 56.98B | ¥ 56.58B | ¥ 49.56B | ¥ 44.03B | ¥ 28.96B |
| Total Debt | ¥ 4.94B | ¥ 4.56B | ¥ 4.42B | ¥ 4.30B | ¥ 3.33B |
| Net Debt | ¥ -3.34B | ¥ -5.11B | ¥ -1.97B | ¥ -4.71B | ¥ -3.76B |
| Total Liabilities | ¥ 11.50B | ¥ 12.56B | ¥ 13.35B | ¥ 11.33B | ¥ 8.06B |
| Stockholders' Equity | ¥ 41.82B | ¥ 40.33B | ¥ 35.05B | ¥ 32.28B | ¥ 20.56B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 1.29B | ¥ 437.20M | ¥ -326.72M | ¥ -3.09B | ¥ -4.14B |
| Operating Cash Flow | ¥ 5.22B | ¥ 4.67B | ¥ 5.54B | ¥ 3.43B | ¥ 1.88B |
| Investing Cash Flow | ¥ -3.94B | ¥ -3.23B | ¥ -5.91B | ¥ -9.60B | ¥ -7.22B |
| Financing Cash Flow | ¥ -2.75B | ¥ 1.96B | ¥ -2.59B | ¥ 8.21B | ¥ 6.57B |